FMR LLC 13D and 13G filings for NovoCure Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:28 am Purchase | 2024-02-08 | 13G | NovoCure Limited NVCR | FMR LLC | 15,962,765 14.937% | 219,251 (+1.39%) | Filing |
| 2023-02-09 12:01 pm Purchase | 2023-02-09 | 13G | NovoCure Limited NVCR | FMR LLC | 15,743,514 14.999% | 5,006,810 (+46.63%) | Filing |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | NovoCure Limited NVCR | FMR LLC | 10,736,704 10.281% | 2,926,367 (+37.47%) | Filing |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | NovoCure Limited NVCR | FMR LLC | 7,810,337 7.522% | -1,835,049 (-19.03%) | Filing |
| 2021-02-08 10:29 am Sale | 2021-02-05 | 13G | NovoCure Limited NVCR | FMR LLC | 9,645,386 9.473% | -2,534,042 (-20.81%) | Filing |